Treosulfan

DB11678

small molecule approved investigational

Deskripsi

Treosulfan is under investigation in Allogeneic Haematopoietic Stem Cell Transplantation. Treosulfan has been investigated for the treatment of Lymphoblastic Leukemia, Acute, Childhood.

Struktur Molekul 2D

Berat 278.29
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

38 Data
Darbepoetin alfa The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Treosulfan.
Erythropoietin The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Treosulfan.
Peginesatide The risk or severity of Thrombosis can be increased when Peginesatide is combined with Treosulfan.
Methoxy polyethylene glycol-epoetin beta The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Treosulfan.
Lidocaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Lidocaine.
Ropivacaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Ropivacaine.
Bupivacaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Bupivacaine.
Cinchocaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Cinchocaine.
Dyclonine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Dyclonine.
Procaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Procaine.
Prilocaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Prilocaine.
Proparacaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Proparacaine.
Meloxicam The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Meloxicam.
Oxybuprocaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Oxybuprocaine.
Cocaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Cocaine.
Mepivacaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Mepivacaine.
Levobupivacaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Levobupivacaine.
Diphenhydramine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Diphenhydramine.
Benzocaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Benzocaine.
Chloroprocaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Chloroprocaine.
Phenol The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Phenol.
Tetrodotoxin The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Tetrodotoxin.
Benzyl alcohol The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Benzyl alcohol.
Capsaicin The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Capsaicin.
Etidocaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Etidocaine.
Articaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Articaine.
Tetracaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Tetracaine.
Propoxycaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Propoxycaine.
Pramocaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Pramocaine.
Butamben The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Butamben.
Butacaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Butacaine.
Oxetacaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Oxetacaine.
Ethyl chloride The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Ethyl chloride.
Butanilicaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Butanilicaine.
Metabutethamine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Metabutethamine.
Quinisocaine The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Quinisocaine.
Ambroxol The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Ambroxol.
Etrasimod The risk or severity of immunosuppression can be increased when Treosulfan is combined with Etrasimod.

Contoh Produk & Brand

Produk: 6 • International brands: 0
Produk
  • Trecondi
    Injection, powder, for solution • 1 g • Intravenous • EU • Approved
  • Trecondi
    Injection, powder, for solution • 1 g • Intravenous • EU • Approved
  • Trecondi
    Injection, powder, for solution • 5 g • Intravenous • EU • Approved
  • Trecondi
    Injection, powder, for solution • 5 g • Intravenous • EU • Approved
  • Trecondyv
    Powder • 1 g / vial • Intravenous • Canada • Approved
  • Trecondyv
    Powder • 5 g / vial • Intravenous • Canada • Approved

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul